Reza Vosoughi

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

John Foley, Gilles Defer, Lana Zhovtis Ryerson et al. · The Lancet Neurology · 2022 · 110 citations

Medicine, Pharmacology, Pharmacotherapy +11

Safety and efficacy of venoplasty in MS

Anthony Traboulsee, Lindsay Machan, J Girard et al. · Neurology · 2018 · 28 citations · Full text

Medicine, Neurology, Surgery +15

Jamestown Canyon virus meningoencephalitis mimicking migraine with aura in a resident of Manitoba

Reza Vosoughi, Andrew Walkty, Michael Drebot et al. · Canadian Medical Association Journal · 2018 · 25 citations · Full text

Medicine, Infectious Diseases, Neurology +13

Cognitive impact of anticholinergic medication in MS: Adding insult to injury?

Roxana Cruce, Reza Vosoughi, Mark S. Freedman · Multiple Sclerosis and Related Disorders · 2012 · 24 citations

Medicine, Neurology, Neuroscience +14

Identification of the Cognitive Interference Effect Related to Stroop stimulation: using Dynamic Causal Modeling of Effective Connectivity in Functional Near-Infrared Spectroscopy (fNIRS)

Yousef Pour M, Sadegh Masjoodi, Marjan Imani Fooladi et al. · Journal of Biomedical Physics and Engineering · 2020 · 16 citations · Full text

Life Sciences, Neuroscience, Psychology +17